Increasing prevalence of multiple sclerosis in Tuscany, Italy.
Administrative data
Increasing prevalence
Italy
Multiple sclerosis
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
Feb 2020
Feb 2020
Historique:
received:
09
03
2019
accepted:
26
09
2019
pubmed:
7
11
2019
medline:
25
11
2020
entrez:
7
11
2019
Statut:
ppublish
Résumé
An increase of prevalence and incidence of multiple sclerosis (MS) has been reported in several countries, especially taking into account a long-term evaluation. This increasing trend often reflects improved case identification and ascertainment due to the refinement of diagnostic criteria. The aim of this study was to update the prevalence rate of MS in Tuscany (central Italy) as of 2017, and to assess if there has been an increasing trend of prevalence in this Region considering a short period of analysis, from 2014 to 2017. To capture prevalent cases, a case-finding algorithm based on administrative data, previously created and validated, was used. As data sources, we considered hospital discharge records, drug-dispensing records, disease-specific exemptions from copayment to health care, home and residential long-term care, and inhabitant registry. As of January 1, 2017, 7809 cases were identified, of which 69.4% were females and 30.6% were males. Considering temporal variation, an increasing trend was observed, with standardized rates rising from 189.2 in 2014 to 208.7 per 100,000 in 2017. Results confirm that prevalence increases every year, probably mainly due to the difference between incidence and mortality, resulting in an increasing trend. Moreover, administrative data may accurately identify MS patients in a routinary way and monitor this cohort along disease care pathways.
Sections du résumé
BACKGROUND AND RATIONALE
OBJECTIVE
An increase of prevalence and incidence of multiple sclerosis (MS) has been reported in several countries, especially taking into account a long-term evaluation. This increasing trend often reflects improved case identification and ascertainment due to the refinement of diagnostic criteria. The aim of this study was to update the prevalence rate of MS in Tuscany (central Italy) as of 2017, and to assess if there has been an increasing trend of prevalence in this Region considering a short period of analysis, from 2014 to 2017.
METHODS
METHODS
To capture prevalent cases, a case-finding algorithm based on administrative data, previously created and validated, was used. As data sources, we considered hospital discharge records, drug-dispensing records, disease-specific exemptions from copayment to health care, home and residential long-term care, and inhabitant registry.
RESULTS
RESULTS
As of January 1, 2017, 7809 cases were identified, of which 69.4% were females and 30.6% were males. Considering temporal variation, an increasing trend was observed, with standardized rates rising from 189.2 in 2014 to 208.7 per 100,000 in 2017.
CONCLUSIONS
CONCLUSIONS
Results confirm that prevalence increases every year, probably mainly due to the difference between incidence and mortality, resulting in an increasing trend. Moreover, administrative data may accurately identify MS patients in a routinary way and monitor this cohort along disease care pathways.
Identifiants
pubmed: 31691867
doi: 10.1007/s10072-019-04090-0
pii: 10.1007/s10072-019-04090-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
397-402Références
Neurol Sci. 2018 Jul;39(7):1231-1236
pubmed: 29671168
J Neurol Sci. 2012 Dec 15;323(1-2):117-22
pubmed: 22995683
Neuroepidemiology. 2014;42(3):154-60
pubmed: 24556851
Epidemiol Prev. 2011 Sep-Dec;35(5-6 Suppl 4):29-152
pubmed: 22166295
Adv Exp Med Biol. 2017;958:141-159
pubmed: 28093712
Neurol Sci. 2015 May;36(5):783-6
pubmed: 25663085
Mult Scler. 2014 Apr;20(5):543-7
pubmed: 24025709
Neuroepidemiology. 2016;46(1):37-42
pubmed: 26618996
Mult Scler. 2015 Feb;21(2):217-24
pubmed: 24948683
Neuroepidemiology. 2018;51(3-4):158-165
pubmed: 30130759
Neurology. 2003 Nov 25;61(10):1373-7
pubmed: 14638958
Neurol Sci. 2015 Feb;36(2):227-34
pubmed: 25109816
J Neurol Sci. 2014 Sep 15;344(1-2):171-81
pubmed: 25062946
J Neurol Neurosurg Psychiatry. 2011 Oct;82(10):1132-41
pubmed: 21478203
Neurol Sci. 2017 Dec;38(12):2183-2187
pubmed: 29019004
Mult Scler. 2011 Mar;17(3):273-80
pubmed: 21071466
Neurol Sci. 2018 Nov;39(11):1881-1885
pubmed: 30090983
Neuroepidemiology. 2019;52(1-2):41-46
pubmed: 30476909
Neurology. 2010 Feb 9;74(6):465-71
pubmed: 20071664
Mult Scler. 2015 Sep;21(10):1244-50
pubmed: 25583850
Neurol Sci. 2017 Mar;38(3):473-479
pubmed: 28040843
IARC Sci Publ. 1994;(128):1-302
pubmed: 7698823
Mult Scler. 2008 Aug;14(7):872-9
pubmed: 18573834
N Engl J Med. 2000 Sep 28;343(13):938-52
pubmed: 11006371
J Neurol. 2016 Apr;263(4):751-9
pubmed: 26886201